PHS
CRBU icon

PFM Health Sciences’s Caribou Biosciences CRBU Stock Holding History

PFM Health Sciences’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Hold
957,787
– – 0.17% 79
2025
Q4 		$1.52M Sell
957,787
-401,044
-30% -$842K 0.15% 72
2025
Q3 		$3.17M Hold
1,358,831
– – 0.24% 62
2025
Q2 		$1.71M Sell
1,358,831
-1,147,604
-46% -$1.13M 0.15% 50
2025
Q1 		$2.29M Sell
2,506,435
-1,370,027
-35% -$1.78M 0.17% 53
2024
Q4 		$6.16M Sell
3,876,462
-430,209
-10% -$865K 0.38% 52
2024
Q3 		$8.44M Buy
4,306,671
+223,299
+5% +$457K 0.48% 43
2024
Q2 		$6.7M Sell
4,083,372
-2,399,898
-37% -$7.67M 0.33% 52
2024
Q1 		$33.3M Buy
6,483,270
+2,506
+0% +$15.5K 1.57% 24
2023
Q4 		$37.1M Sell
6,480,764
-243,951
-4% -$1.21M 2.23% 16
2023
Q3 		$32.1M Buy
6,724,715
+1,153,846
+21% +$7.16M 1.51% 29
2023
Q2 		$23.7M Buy
5,570,869
+558,751
+11% +$2.51M 0.92% 44
2023
Q1 		$26.6M Buy
5,012,118
+552,335
+12% +$3.44M 1.18% 37
2022
Q4 		$28M Sell
4,459,783
-1,540,217
-26% -$13.7M 1% 41
2022
Q3 		$63.3M Hold
6,000,000
– – 2.29% 11
2022
Q2 		$32.6M Buy
6,000,000
+1,629,455
+37% +$12.5M 1.24% 37
2022
Q1 		$40.1M Buy
4,370,545
+278,236
+7% +$2.93M 1.5% 29
2021
Q4 		$59.4M Hold
4,092,309
– – 2.02% 15
2021
Q3 		$88.2M Buy
+4,092,309
New +$100M 2.59% 10

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PFM Health Sciences's CRBU Position: Q1 2026 in Review

PFM Health Sciences held its Caribou Biosciences (CRBU) position steady in Q1 2026 at 957,787 shares worth $1.82M. The position accounts for 0.17% of the portfolio, ranked #79.

PFM Health Sciences first reported a position in CRBU in Q3 2021 and has held it in 19 quarters since. The position peaked at $88.2M in Q3 2021. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • PFM Health Sciences held 957,787 shares of Caribou Biosciences worth $1.82M as of Q1 2026.
  • PFM Health Sciences left its Caribou Biosciences share count unchanged in Q1 2026.
  • Caribou Biosciences made up 0.17% of PFM Health Sciences's portfolio in Q1 2026, its #79 holding.
  • PFM Health Sciences first reported a position in Caribou Biosciences in Q3 2021 and has held it in 19 quarters since.
  • PFM Health Sciences's Caribou Biosciences position peaked at $88.2M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.